Transcripts Sensorion

Stocks

ALSEN

FR0012596468

Biotechnology & Medical Research

Market Closed - Euronext Paris 19:55:00 11/09/2026 +04			5-day change	1st Jan Change
0.2280 ^EUR	-1.94%		-8.25%	-32.34%

09-03	Sensorion Receives Clinical Trial Authorization in France for SENS-601 Gene Therapy for Gjb2-Related Hearing Loss	CI
09-03	Sensorion Gets Go-ahead in France for Trial of Lead Gene Therapy Candidate for Hearing Loss	MT

Transcripts

15/01/25

Sensorion SA Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 04:30 PM

No results match your criteria

All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!